Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US4584320A · kind A · utility
11Cited by
1References
13Claims
0Family size
Inventor
Key dates
| Filing date | Jan 3, 1985 |
| Grant date | Apr 22, 1986 |
| Priority date | — |
| Expiry date | Jan 3, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of asthma, nasal congestion and anaphylactic shock involves nasal or oral administration of 8,11,14,17-eicosatetraenoic acid. Pharmaceutical compositions for this purpose are prepared containing 8,11,14,17-eicosatetraenoic acid and pharmaceutically acceptable vehicles, as well as, preferably, a suitable anti-oxidant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.